The challenge of improved diagnostic and prognostic indicators of superficial bladder cancer

Editorial

D L Lamm. J Urol. 2000 Sep.

. 2000 Sep;164(3 Pt 1):690-1.

doi: 10.1097/00005392-200009010-00017.

No abstract available

Comment on

Clinical usefulness of the novel marker BLCA-4 for the detection of bladder cancer.
Konety BR, Nguyen TS, Brenes G, Sholder A, Lewis N, Bastacky S, Potter DM, Getzenberg RH. Konety BR, et al. J Urol. 2000 Sep;164(3 Pt 1):634-9. doi: 10.1097/00005392-200009010-00004. J Urol. 2000. PMID: 10953114
The 3-month clinical response to intravesical therapy as a predictive factor for progression in patients with high risk superficial bladder cancer.
Solsona E, Iborra I, Dumont R, Rubio-Briones J, Casanova J, Almenar S. Solsona E, et al. J Urol. 2000 Sep;164(3 Pt 1):685-9. doi: 10.1097/00005392-200009010-00016. J Urol. 2000. PMID: 10953125
Primary superficial bladder cancer risk groups according to progression, mortality and recurrence.
Millán-Rodríguez F, Chéchile-Toniolo G, Salvador-Bayarri J, Palou J, Algaba F, Vicente-Rodríguez J. Millán-Rodríguez F, et al. J Urol. 2000 Sep;164(3 Pt 1):680-4. doi: 10.1016/s0022-5347(05)67280-1. J Urol. 2000. PMID: 10954628